Novo Nordisk A/S, Denmark
Brendan is Global Medical Director in Cell Therapy in Novo Nordisk Global Medical Affairs, based in Denmark He is rresponsible for providing medical and scientific insights, promoting the patient voice in cell therapy development, engaging with external experts, and leading scientific dialogue activities. Prior to joining Novo Nordisk, Brendan worked in paediatric and neonatal surgery in Australia and Great Britain for more than 10 years. He holds a Ph.D. in stem cell biology and regenerative medicine from University College London.
PROGRESSING CELL THERAPIES TO CLINIC: UNDERSTANDING THE CELLULAR DRUG PRODUCT
Friday, July 12, 2024
8:15 AM – 9:45 AM CEST